Elsewhere, stronger FASN expression was described in a paclitaxel-resistant hepatocellular carcinoma cell line, Hep3B, than in its paclitaxel-sensitive parental clone [13]. The gene discussed is FASN; the disease is hepatocellular carcinoma.